aslan pharmaceuticals pte ltd

ASLAN & CSL To Develop Asthma Treatment

ASLAN acquires license for CSL334, an anti-IL13 receptor monoclonal antibody for the treatment of asthma.

ASLAN Pharmaceuticals Opens Taiwan Office

Biotech company ASLAN Pharmaceuticals Pte Ltd, which is headquartered in Singapore, has opened a new office in Taipei, Taiwan.

ASLAN Pharmaceuticals Secures US$22m In Series B Financing

ASLAN Pharmaceuticals has raised US$22 million after hosting a second round of financing with Cenova Ventures.

ASLAN’s Pan-HER Inhibitor Shows Positive Data In Gastric Cancer PhII Study

ASLAN Pharma announced this week positive data with ASLAN001 in a gastric cancer Phase II study.

ASLAN Pharma To Develop Bristol-Myers Squibb’s BMS-777607 Compound

ASLAN Pharma and Bristol-Myers Squibb will co-develop an investigational small molecule inhibitor of the MET receptor tyrosine kinase for treatment of solid tumors.